Pfizer’s proposed $43 billion takeover of Seagen Inc. is currently under the microscope of the Federal Trade Commission (FTC). Amidst an industry-wide string of attempted mergers and acquisitions, the FTC has launched an extensive antitrust review of the high-profile deal.
Seagen claimed that both companies have been served a “second request” seeking additional information to fuel the review. Originally, the filing was withdrawn in June, but Pfizer and Seagen then resubmitted it to grant the FTC more time to conduct their initial evaluation.
“We continue to expect that the acquisition of Seagen by Pfizer will be completed in late 2023 or early 2024,” said Seagen in a regulatory filing, reported Reuters.
Yet even this optimistic prediction has been clouded by the scrutiny of the FTC blocking Amgen’s attempted purchase of Horizon Therapeutics for $27.8 billion, leaving investors on edge.
Read more: French Government Criticizes Appointment Of US Economist As Chief Antitrust Advisor
Commenting on the acquisition, Alicia Dubuc of the FTC said: “We recognize the need to examine with particular scrutiny proposed mergers that may result in lessening of competition and higher prices for consumers. We remain diligent in protecting the American public from these potential harms.”
The Pfizer-Seagen deal is being viewed as an indicator of the Federal Trade Commision’s attitude towards mergers and acquisitions amongst biopharmaceutical firms. As investors anxiously await the results of the review, it will likely set a long-term trend across the industry.
Source: Reuters
Featured News
Mexico Moves Forward with Reform to Eliminate Key Regulators, Including Competition Watchdog
Aug 23, 2024 by
CPI
DOJ Sues RealPage for Alleged Rent-Fixing Scheme Using AI Software
Aug 23, 2024 by
CPI
Advance Auto Parts to Offload Worldpac for $1.5 Billion
Aug 22, 2024 by
CPI
Bronfman Ups Ante to $6 Billion in Paramount Battle, Skydance Deal at Risk
Aug 22, 2024 by
CPI
Google and California Strike Historic Deal to Fund Newsrooms Amid Controversy
Aug 22, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – State Attorneys General
Aug 22, 2024 by
CPI
CPI Talks… …With Attorney General Phil Weiser
Aug 22, 2024 by
CPI
The Bipartisan Miracle of State Antitrust Enforcement
Aug 22, 2024 by
Gwendolyn J. Lindsay Cooley
Recent Developments in State Antitrust Enforcement: Agriculture and Food Markets
Aug 22, 2024 by
Elizabeth R. Odette
State Attorneys General: Stewards of Consumer Health and Welfare
Aug 22, 2024 by
Brooke Howlett Lovrovich